Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Agnès Farrugia"'
Autor:
Bérénice Hebrard, Marie-Lise Babonneau, Philippe Charron, Emilie Consolino, Benjamin Dauriat, Delphine Dupin-Deguine, Dominique Fargeaud, Agnès Farrugia, Anna-Gaëlle Giguet-Valard, Damien Guijarro, Jocelyn Inamo, Julien Jeanneteau, Jean-Michaël Mazzella, Claire-Cécile Michon, Gilles Millat, Frédéric Mouquet, Silvia Oghina, Yann Pereon, Vianney Poinsignon, Julie Pompougnac, Julie Proukhnitzky, Elise Schaefer, Franck Sturtz, Mathilde Trosdorf, Anne Auguste, Giorgia Canali, Alexandre Combes, Benoît Funalot, Thibaud Damy
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-7 (2024)
Abstract Transthyretin amyloidosis (ATTR) is a severe and rare disease characterized by the progressive deposition of misfolded transthyretin proteins, causing irreversible organ damage. Transthyretin amyloidosis can present as a hereditary ATTR or a
Externí odkaz:
https://doaj.org/article/6837d07291f54d4ca8e62c50336819cd
Autor:
Thibaud Damy, Guillaume Bourel, Michel Slama, Vincent Algalarrondo, Olivier Lairez, Pauline Fournier, Jérôme Costa, Françoise Pelcot, Agnès Farrugia, Isabelle Durand Zaleski, Hervé Lilliu, Caroline Rault, Mathilde Bartoli, Stéphane Fievez, Anna Granghaud, Jeremie Rudant, Agathe Coste, Charlotte Noirot Cosson, Pierre-Alexandre Squara, Marion Narbeburu, Bertrand De Neuville, Philippe Charron
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Background Precise data about ATTR-CM incidence rates at national level are scarce. Consequently, this study aimed to estimate the annual incidence and survival of transthyretin amyloid cardiomyopathy (ATTR-CM) in France between 2011 and 201
Externí odkaz:
https://doaj.org/article/6947c5f5497e43788cf4bba80c998e29
Autor:
Laura Obici, Joanne Ablett, Teresa Coelho, Thirusha Lane, Isabel Conceicao, Rosaline Callaghan, Catilena Bibiloni, Teofila Bueser, Francesca Dongiglio, Agnès Farrugia, Fabian Knebel, Lars-Ove Larsson, Agnès Morier, Vincent Nicholas
Publikováno v:
BMJ Open, Vol 13, Iss 9 (2023)
Background Hereditary transthyretin-mediated amyloidosis is a rare, progressive and potentially life-limiting multisystem disease, affecting every aspect of a patient’s life.Objectives This online international Delphi survey aimed to evolve clinica
Externí odkaz:
https://doaj.org/article/fabc64414aec4a8e9e2563d5c235b42f
Autor:
Thibaud Damy, David Adams, Frank Bridoux, Gilles Grateau, Violaine Planté-Bordeneuve, Yves Ghiron, Agnès Farrugia, Françoise Pelcot, Charles Taieb, Céline Labeyrie, Arnaud Jaccard, Sophie Georgin-Lavialle
Publikováno v:
Amyloid: The Journal of Protein Folding Disorders
Amyloid: The Journal of Protein Folding Disorders, Taylor & Francis, In press, pp.1-10. ⟨10.1080/13506129.2022.2035354⟩
Amyloid: The Journal of Protein Folding Disorders, Taylor & Francis, In press, pp.1-10. ⟨10.1080/13506129.2022.2035354⟩
International audience; BackgroundAmyloidosis is a complex group of rare conditions. For patients, amyloidosis is severely debilitating: physically and psychologically. Currently, data are lacking to evaluate the medical, economic, and social burden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987edbdb610bd56e06518cdedce27ece
https://doi.org/10.1080/13506129.2022.2035354
https://doi.org/10.1080/13506129.2022.2035354